<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Elsevier BV</publisher>
				<availability status="unknown"><p>Copyright Elsevier BV</p>
				</availability>
				<date type="published" when="2016-04-15">2016 April 15.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vinicius</forename><forename type="middle">M</forename><surname>Alves</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Faculty of Pharmacy</orgName>
								<orgName type="laboratory">Laboratory of Molecular Modeling and Design</orgName>
								<orgName type="institution">Federal University of Goiás</orgName>
								<address>
									<postCode>74605-220</postCode>
									<settlement>Goiânia</settlement>
									<region>GO</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Division of Chemical Biology and Medicinal Chemistry</orgName>
								<orgName type="department" key="dep2">Eshelman School of Pharmacy</orgName>
								<orgName type="laboratory">Laboratory for Molecular Modeling</orgName>
								<orgName type="institution">University of North Carolina</orgName>
								<address>
									<addrLine>Chapel Hill</addrLine>
									<postCode>27599</postCode>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eugene</forename><surname>Muratov</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Division of Chemical Biology and Medicinal Chemistry</orgName>
								<orgName type="department" key="dep2">Eshelman School of Pharmacy</orgName>
								<orgName type="laboratory">Laboratory for Molecular Modeling</orgName>
								<orgName type="institution">University of North Carolina</orgName>
								<address>
									<addrLine>Chapel Hill</addrLine>
									<postCode>27599</postCode>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="laboratory">Laboratory of Theoretical Chemistry</orgName>
								<orgName type="institution">A.V. Bogatsky Physical-Chemical Institute NAS of Ukraine</orgName>
								<address>
									<postCode>65080</postCode>
									<settlement>Odessa</settlement>
									<country key="UA">Ukraine</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Denis</forename><surname>Fourches</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Division of Chemical Biology and Medicinal Chemistry</orgName>
								<orgName type="department" key="dep2">Eshelman School of Pharmacy</orgName>
								<orgName type="laboratory">Laboratory for Molecular Modeling</orgName>
								<orgName type="institution">University of North Carolina</orgName>
								<address>
									<addrLine>Chapel Hill</addrLine>
									<postCode>27599</postCode>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Judy</forename><surname>Strickland</surname></persName>
							<affiliation key="aff3">
								<orgName type="laboratory">ILS/Contractor supporting the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM)</orgName>
								<address>
									<addrLine>Research Triangle Park</addrLine>
									<postBox>P.O. Box 13501</postBox>
									<postCode>27709</postCode>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicole</forename><surname>Kleinstreuer</surname></persName>
							<affiliation key="aff3">
								<orgName type="laboratory">ILS/Contractor supporting the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM)</orgName>
								<address>
									<addrLine>Research Triangle Park</addrLine>
									<postBox>P.O. Box 13501</postBox>
									<postCode>27709</postCode>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carolina</forename><forename type="middle">H</forename><surname>Andrade</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Faculty of Pharmacy</orgName>
								<orgName type="laboratory">Laboratory of Molecular Modeling and Design</orgName>
								<orgName type="institution">Federal University of Goiás</orgName>
								<address>
									<postCode>74605-220</postCode>
									<settlement>Goiânia</settlement>
									<region>GO</region>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Tropsha</surname></persName>
							<email>alex_tropsha@unc.edu</email>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Division of Chemical Biology and Medicinal Chemistry</orgName>
								<orgName type="department" key="dep2">Eshelman School of Pharmacy</orgName>
								<orgName type="laboratory">Laboratory for Molecular Modeling</orgName>
								<orgName type="institution">University of North Carolina</orgName>
								<address>
									<addrLine>Chapel Hill</addrLine>
									<postCode>27599</postCode>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Eshelman School of Pharmacy</orgName>
								<orgName type="institution">University of North Carolina</orgName>
								<address>
									<addrLine>Chapel Hill, NC</addrLine>
									<postCode>27599</postCode>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Toxicology and Applied Pharmacology</title>
						<title level="j" type="abbrev">Toxicology and Applied Pharmacology</title>
						<idno type="ISSN">0041-008X</idno>
						<imprint>
							<publisher>Elsevier BV</publisher>
							<biblScope unit="volume">284</biblScope>
							<biblScope unit="issue">2</biblScope>
							<biblScope unit="page" from="273" to="280"/>
							<date type="published" when="2016-04-15">2016 April 15.</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1016/j.taap.2014.12.013</idno>
					<idno type="PMID">25560673</idno>
					<idno type="PMCID">PMC4408226</idno>
					<ptr type="open-access" target="http://europepmc.org/articles/pmc4408226?pdf=render" />
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T21:24+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Skin sensitization</term>
					<term>skin permeability</term>
					<term>QSAR</term>
					<term>virtual screening</term>
					<term>skin toxicants</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Skin permeability is widely considered to be mechanistically implicated in chemically-induced skin sensitization. Although many chemicals have been identified as skin sensitizers, there have been very few reports analyzing the relationships between molecular structure and skin permeability of sensitizers and non-sensitizers. The goals of this study were to: (i) compile, curate, and integrate the largest publicly available dataset of chemicals studied for their skin permeability; (ii) develop and rigorously validate QSAR models to predict skin permeability; and (iii) explore the complex relationships between skin sensitization and skin permeability. Based on the largest publicly available dataset compiled in this study, we found no overall correlation between skin permeability and skin sensitization. In addition, cross-species correlation coefficient between human and rodent permeability data was found to be as low as R 2 =0.44. Human skin permeability models based on the random forest method have been developed and validated using OECDcompliant QSAR modeling workflow. Their external accuracy was high (Q 2 ext = 0.73 for 63% of external compounds inside the applicability domain). The extended analysis using both experimentally-measured and QSAR-imputed data still confirmed the absence of any overall</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Skin sensitization is a complex adverse toxicological endpoint that is influenced by several biological parameters, such as protein binding, dendritic cell activation, individual variation, and time-dose exposure <ref type="bibr" target="#b21">(Jaworska et al., 2011;</ref><ref type="bibr" target="#b22">Johansen et al., 2011)</ref>. Skin permeability is also often considered as a potential parameter affecting chemicals' sensitization potential <ref type="bibr" target="#b27">(MacKay et al., 2013)</ref>. It relates to the ability of a molecule to pass through the skin, a characteristic which is primarily influenced by the physicochemical properties of the chemical as well as the physicochemical and biological properties of the membrane <ref type="bibr" target="#b48">(Xia, 2011)</ref>.</p><p>Despite the high importance of skin permeability for consumer product efficacy and its supposed influence on potential toxicities such as skin sensitization, the amount of experimental data available in the public domain is surprisingly limited. In the early 90's, a compilation of data points for skin permeability gathered from several sources was published <ref type="bibr" target="#b14">(Flynn, 1990)</ref>. Subsequent studies added some complementary data allowing researchers to develop Quantitative Structure-Activity Relationship (QSAR) models for predicting skin permeability. However, as shown in <ref type="table" target="#tab_1">Table S1</ref>, most of the published studies reporting on skin permeability modeling <ref type="bibr" target="#b0">(Abraham et al., 1999;</ref><ref type="bibr" target="#b3">Barratt, 1995;</ref><ref type="bibr" target="#b4">Berge, 2009;</ref><ref type="bibr" target="#b10">Chen et al., 2010</ref><ref type="bibr" target="#b11">Chen et al., , 2007</ref><ref type="bibr" target="#b12">Cronin et al., 1999;</ref><ref type="bibr" target="#b18">Hostýnek and Magee, 1997;</ref><ref type="bibr" target="#b26">Lien and Gao, 1995;</ref><ref type="bibr" target="#b28">Magnusson et al., 2004;</ref><ref type="bibr" target="#b30">Moss and Cronin, 2002;</ref><ref type="bibr" target="#b31">Moss et al., 2011;</ref><ref type="bibr" target="#b36">Patel et al., 2002;</ref><ref type="bibr">Guy, 1995, 1992)</ref> have not included certain critical elements of QSAR model development and validation protocol, such as the definition of the applicability domain (AD) or proof of passing the Y-randomization test, which constitute best practices of QSAR modeling <ref type="bibr">(OECD, 2004;</ref><ref type="bibr" target="#b43">Tropsha, 2010)</ref>. Recently, several QSAR studies were benchmarked on a series of 11 compounds and all of them failed to predict skin permeation quantitatively; they were only able to rank permeants <ref type="bibr" target="#b7">(Brown et al., 2012)</ref>. Another recent study showed that most of the available QSAR models underestimate the skin permeability of hydrophilic solutes <ref type="bibr" target="#b9">(Chen et al., 2013)</ref>. Recent studies <ref type="bibr" target="#b8">(Chauhan and Shakya, 2010)</ref> attempted to overcome the related problems with complex chemical mixtures and built a QSAR model based on several mixtures of 36 chemicals with porcine skin data. The latter model followed the best practices of QSAR modeling <ref type="bibr" target="#b43">(Tropsha, 2010)</ref>; however, we have identified 21 duplicative structures in that dataset (see <ref type="table">Table S3</ref>) indicating a potential bias of the model and a likely over-estimation of its true performance.</p><p>Despite the underlying importance of skin permeability and its identification as a necessary step in the OECD Adverse Outcome Pathway (AOP) for skin sensitization <ref type="bibr" target="#b23">(Karlberg et al., 2008</ref>; OECD, 2012), we could not find any study among those compiled in <ref type="table" target="#tab_1">Tables S1 and  S2</ref>, where both endpoints were analyzed concurrently and in the context of their possible inter-dependency. The prevalence of dermal exposure to diverse chemicals in consumer products and in the environment, the importance of permeability for skin sensitization, and the lack of reliable models to predict these endpoints for new chemicals have motivated us to initiate a tandem study on collecting and analyzing both skin permeability and skin sensitization data. In the companion paper <ref type="bibr" target="#b1">(Alves et al., 2014)</ref>, we have reported on new QSAR models of skin sensitization. In this study, we have compiled, curated, and integrated skin permeability coefficient (Kp) data extracted from various literature sources. Using this unique data collection, we have developed and rigorously validated QSAR models for skin permeability, and explored the relationships between the skin sensitization potential and the chemical permeability coefficient. The QSAR models developed in this and the accompanying study <ref type="bibr" target="#b1">(Alves et al., 2014)</ref> are publicly available and can be used for evaluating chemically induced skin effects in silico as part of both research and development projects as well as in support of regulatory decisions on consumer products.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Datasets</head><p>Skin sensitization datasets (datasets A and B)-In the Part I of this study <ref type="bibr" target="#b1">(Alves et al., 2014)</ref> we described two skin sensitization datasets. Briefly, one of them (dataset A) was retrieved from the ICCVAM (Interagency Coordinating Committee on the Validation of Alternative Methods) report on the murine reduced local lymph node assay <ref type="bibr" target="#b19">(ICCVAM 2009)</ref>. The modeling set (Dataset A) consisted of 254 compounds (127 sensitizers and 127 non-sensitizers) and the external validation set (dataset B) consisted of 133 sensitizers from the ICCVAM report <ref type="bibr" target="#b19">(ICCVAM 2009)</ref> and 18 additional compounds taken from the study of <ref type="bibr" target="#b21">Jaworska et al. (2011)</ref>. This collection of data was used to explore the intrinsic relationship between skin sensitization and skin permeability (human data from dataset D; see below) for a subset of 20 compounds from the same dataset for which both skin sensitization and skin permeability data were known.</p><p>Human skin permeability dataset (dataset D)-In vitro human skin permeability coefficients were retrieved from the literature <ref type="bibr" target="#b8">(Chauhan and Shakya, 2010)</ref> including 211 records expressed in logKp (cm.h −1 ); this dataset contained the well-known and frequently studied Flynn dataset <ref type="bibr" target="#b14">(Flynn, 1990)</ref>. 17 duplicates and two sets of triplicates were identified and curated leaving unique compounds only. Three additional compounds and water were also removed for the following reasons: both styrene (logKp = −0.19) and ethyl benzene (logKp = 0.08) were identified as activity outliers (i.e., their logKp values were far outside the activity range of the other compounds in the dataset between −5.52 and −0.69) whereas digitoxin (natural product) was a structural outlier. The remaining 186 compounds (dataset D) were retained for modeling.</p><p>Rodent dataset (dataset E)-The set of in vitro rodent skin permeability data consisting of 103 chemical compounds was retrieved from the literature <ref type="bibr" target="#b31">(Moss et al., 2011)</ref>. After curation, 96 compounds (dataset E) were kept for modeling. The following five activity outliers were removed from the dataset E: bisphenol A diglycidyl ether (−5.26), decabromodiphenyl oxide (−5.15), 4-N butylamine (−0.64), bufexamac (−0.57), and triclosan (0.13). The overall range of logKp for the final dataset varied from −4.85 to −0.94.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data curation</head><p>Chemical structures were retrieved either from PubChem (https:// pubchem.ncbi.nlm.nih.gov/, accessed in March 2012) or ChemSpider (http:// www.chemspider.com/, accessed in March 2012) databases using chemical names. Chemicals were removed if their structures could not be found. Each dataset was carefully curated according to previously established guidelines <ref type="bibr" target="#b17">(Fourches et al., 2010)</ref>. Briefly, counterions were removed, whereas specific chemotypes such as aromatic and nitro groups were normalized using the ChemAxon Standardizer (v.5.3, ChemAxon, Budapest, Hungary, http://www.chemaxon.com). The presence of duplicates, i.e., identical compounds reported more than once in the same dataset, is known to lead to over-optimistic estimations of the predictivity for developed QSAR models. However, the analysis of such records also gives an estimate of the dataset quality: if activity data for the same compound are consistent, the overall data quality is high; if there is a large deviation in experimental values between different records of the same compound, the quality is, obviously, low. Thus, after the structural standardization, the duplicates were identified using ISIDA Duplicates <ref type="bibr" target="#b46">(Varnek et al., 2008)</ref> and <ref type="bibr">HiT QSAR (Kuz'min et al., 2008)</ref> software and carefully analyzed. If the experimental properties associated with two duplicative structures were identical, or highly similar, then one compound was chosen at random and deleted. However, if their experimental properties were significantly different, we deleted both records from the dataset. During the curation of human skin permeability dataset, we found 17 pairs of duplicate structures and two sets of triplicates as shown in <ref type="table">Table S3</ref>. The permeability values for duplicative records were almost identical (logKp variation ~ 0.01 LU) except those for butanoic acid that had a variation higher than ca. 0.4 LU. Thus, the LogKp value for all 17 compounds was averaged and the duplicative records were removed so that only one permeability coefficient was used for a chemical compound.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cheminformatics Approaches</head><p>Hierarchical Cluster Analysis-The clustering of a chemical dataset consists of merging compounds into distinct clusters of chemically similar molecules [see <ref type="bibr" target="#b13">(Downs and Barnard, 2003;</ref><ref type="bibr" target="#b29">Mercier, 2003)</ref> for a review of the most popular clustering approaches used in computational chemistry]. In this study, we have employed the Sequential Agglomerative Hierarchical Non-overlapping (SAHN) method implemented in the ISIDA/Cluster program (http://infochim.u-strasbg.fr) <ref type="bibr" target="#b47">(Varnek et al., 2007)</ref>. Briefly, each compound represents one cluster at the start. Then, the m compounds are merged iteratively into clusters using their pairwise Euclidean distances stored in a squared (m * m) symmetric distance matrix. The two closest objects (molecules or clusters) are iteratively identified and merged to form a new cluster, the distance matrix being updated with the re-computed distances separating the newly formed cluster and the others, according to the user-specified type of linkage (complete linkage in this study). The process is repeated until one cluster remains. The parent-child relationships between clusters result in a hierarchical data representation, or dendrogram. In particular, we used ISIDA/Cluster to obtain the heat map (see Results section) of the proximity matrix.</p><p>Dragon Descriptors-The following types of descriptors were generated using Dragon software (v.5.5, Talete SRL, Milan, Italy): 0D constitutional (atom and group counts), 1D functional groups, 1D atom-centered fragments, 2D topological descriptors, 2D walk and path counts, 2D autocorrelations, 2D connectivity indices, 2D information indices, 2D topological charge indices, 2D eigenvalue-based indices, 2D topological descriptors, 2D edge-adjacency indices, 2D Burden eigenvalues, 2D binary fingerprints, 2D frequency fingerprints, and molecular properties. The detailed discussion for these descriptors can be found elsewhere <ref type="bibr" target="#b42">(Todeschini and Consonni, 2000)</ref>.</p><p>SiRMS Descriptors-2D Simplex Representation of Molecular Structure (SiRMS) descriptors <ref type="bibr" target="#b32">(Muratov et al., 2010</ref>) (representing numbers of unique tetratomic fragments with fixed composition and topological structure) were generated by the HiT QSAR software <ref type="bibr" target="#b24">(Kuz'min et al., 2008)</ref>. At the 2D level, the connectivity of atoms in a simplex, atom type, and bond nature (single, double, triple, or aromatic) have been considered. SiRMS descriptors account not only for the atom type, but also for other atomic characteristics that may impact biological activity of molecules, e.g., partial charge, lipophilicity, refraction, and an atom ability for being a donor/acceptor in hydrogen-bond formation (H-bond). For atom characteristics with continuous values (charge, lipophilicity, and refraction) the division of the entire value range into definite discrete groups has been carried out. The atoms have been divided into four groups corresponding to their (i) partial charge A≤−0.05&lt;B≤0&lt;C≤0.05&lt;D, (ii) lipophilicity A≤−0.5&lt;B≤0&lt;C≤0.5&lt;D, and (iii) refraction A≤1.5&lt;B≤3&lt;C≤8&lt;D. For H-bond characteristic, the atoms have been divided into three groups: A (acceptor of hydrogen in H-bond), D (donor of hydrogen in H-bond), and I (indifferent atom). The usage of sundry variants of differentiation of simplex vertexes (atoms) represents the principal feature of the SiRMS approach <ref type="bibr" target="#b25">(Kuz'min et al., 2007)</ref>. Detailed description of HiT QSAR and SiRMS can be found elsewhere <ref type="bibr" target="#b24">(Kuz'min et al., 2008;</ref><ref type="bibr" target="#b32">Muratov et al., 2010)</ref>.</p><p>QSAR modeling-The QSAR modeling workflow used in this study includes three major steps <ref type="bibr" target="#b44">(Tropsha and Golbraikh, 2007;</ref><ref type="bibr" target="#b43">Tropsha, 2010)</ref>: (i) data curation/preparation/analysis (selection of compounds and descriptors), (ii) model building, and (iii) model validation/ selection. Here we followed a 5-fold external cross-validation procedure: the full set of compounds with known experimental activity is randomly divided into five subsets of equal size; then one of these subsets (20% of all compounds) is set aside as an external validation set and the remaining four sets together form the modeling set (80% of the full set). This procedure is repeated five times allowing each of the five subsets to be used as external validation set. Models are built using the modeling set only, and it is important to emphasize that the compounds in corresponding external set (fold) are never employed either to build and/or select the models. Each modeling set is divided into many internal training and test sets; then models are built using compounds of each training set and applied to test set compounds to assess their properties. The statistical metrics used to assess different aspects of model performance are available in the Supplementary Materials.</p><p>Best models were identified and selected according to acceptable threshold values (&gt; 0.6) of for the internal test sets (called out-of-bag set in Random Forest, vide infra). Then, selected models were applied to the external set compounds to predict their skin sensitization potential. This procedure was repeated five times to ensure that every compound was present once and only once in the corresponding external test set. Since the accuracy of each model is estimated only based on external set compounds, which are never used to derive, bias, or select models, this protocol ensures an objective estimation of the true external predictivity of the models. In addition, 1,000 rounds of Y-randomization were performed for each dataset to assure that the high accuracy of the models built with real data was not due to chance correlations.</p><p>Random Forest-Random Forest models were constructed according to the original RF algorithm <ref type="bibr" target="#b6">(Breiman, 2001</ref>) using the CF software version 2.12 <ref type="bibr" target="#b37">(Polishchuk et al., 2009)</ref>. RF is an ensemble of single decision trees. Outputs of all trees are aggregated to obtain one final prediction. Each tree is grown as follows: (i) a bootstrap sample is produced from the whole set of N compounds to form a training set for the current tree. Compounds that are not in the training set of the current tree are placed in the out-of-bag (OOB) set (size of ~ N/3); (ii) the best split by CART algorithm <ref type="bibr" target="#b5">(Breiman et al., 1984)</ref> among the m randomly selected descriptors from the entire pool in each node is chosen; (iii) each tree is then grown to the largest possible extent; there is no pruning. The predicted classification values are defined by majority voting for one of the classes. Thus, each tree predicts values for only those compounds that are not included in the training set of that tree (for OOB set only). Since RF possesses its own reliable statistical characteristics (based on OOB set prediction) which could be used for validation and model selection, no cross-validation was performed <ref type="bibr" target="#b6">(Breiman, 2001)</ref>. Thus, the final model is chosen by the lowest error for prediction of the OOB set. The local (tree) applicability domain approach <ref type="bibr" target="#b2">(Artemenko et al., 2011)</ref> was used for all RF models developed in this study. where K o/w is the octanol/water partition coefficient and MW is the molecular weight of the chemical. Human skin permeability dataset (dataset D) was imported to DERMWIN as SMILES strings, and logKp was calculated and compared to the predictions of our models.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DERMWIN-The</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Relationship between human and rodent skin permeability coefficients</head><p>First, we searched for the subset of chemicals that had both human and rodent skin permeability data available to verify whether we could increase the dataset size by merging these data. We found 34 compounds that have both human and rodent experimental data. As is obvious from <ref type="figure">Figure 1</ref>, the correlation between human and rodent data was not high enough to merge these datasets.</p><p>A linear regression of the logKp values yielded R 2 =0.44 only. Therefore, we decided that the data for humans and rodents were definitely not compatible and built species-specific QSAR models. Human-based and rodent-based QSAR models for skin permeability were developed using the same protocol used for skin sensitization as described in the companion paper <ref type="bibr" target="#b1">(Alves et al., 2014)</ref>. The results <ref type="table" target="#tab_1">(Table 1</ref>) suggest that continuous models for both datasets afforded high predictive accuracy as estimated by Q 2 ext values. However, the quality and coverage of human-based models 12 and 14 were higher than the same characteristics of the best rodent-based model 21. Thus, models 12 and 14 were retained for in silico screening of chemical libraries of concern to identify potential human skin sensitizers. Additional statistical characteristics of the models are present in Supplementary Materials <ref type="table">(Table S2</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Relationship between skin sensitization and permeability</head><p>We have explored whether there are intrinsic relationships between skin sensitization and skin permeability of chemicals. Since rodent data did not correlate well with human data, only human skin permeability data were employed for this analysis. We identified a subset of 20 compounds for which both skin sensitization and skin permeability data were known. These experimental data were compiled from several studies <ref type="bibr" target="#b8">(Chauhan and Shakya, 2010;</ref><ref type="bibr" target="#b19">ICCVAM, 2009;</ref><ref type="bibr" target="#b21">Jaworska et al., 2011)</ref>. As shown in <ref type="table">Table 2</ref>, there is no direct relationship between the two endpoints. The ranges of logKp values for sensitizers (logKp = −3.62 -−1.28) vs. non-sensitizers (logKp = −3.05 -−1.6) confirm this finding. For instance, five non-sensitizers have low permeability coefficient while logKp values for two other nonsensitizers are high. There is a common understanding that a chemical should penetrate the skin to cause sensitization (penetration is generally regarded as the first step in the skin sensitization AOP <ref type="bibr" target="#b23">(Karlberg et al., 2008;</ref><ref type="bibr">OECD, 2012)</ref>). However, we found examples when a relatively weak penetrant can still be a strong sensitizer (e.g., p-Phenylenediamine, logKp = −3.62), whereas a strong penetrant, can be a non-sensitizer (e.g., octanoic acid, logKp = −1.60). This observation suggests that skin permeability and skin sensitization are generally decoupled processes and therefore it may be possible to modify chemicals such as to affect permeability without affecting sensitization, and vice versa.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cluster analysis of human skin permeability dataset</head><p>We have performed a cluster analysis of the human skin permeability set (dataset D) following the same method used for the skin sensitization dataset A (part I in <ref type="bibr" target="#b1">(Alves et al., 2014)</ref>). Due to the poor concordance between human and rodent data, and a heightened interest in human skin permeability data, this analysis was only conducted using dataset D.</p><p>As illustrated in <ref type="figure">Figure 2</ref>, the dendrogram for the dataset D is not as extensive as for skin sensitization dataset A <ref type="bibr" target="#b1">(Alves et al., 2014)</ref>, i.e., compounds in the skin penetration dataset D are more structurally similar than those in the skin sensitization dataset A. Short-chain alcohols have similar logKp values (ca. −3.0) except for ethylene glycol (logKp = −4.07). For glycol ethers with short carbon chains (cluster b in <ref type="figure">Figure 2</ref>), the decrease of permeability is likely related to the chain length (2-(2-methoxyethoxy)ethanol (logKp= −3.69) &lt; 2-(2-ethoxyethoxy)ethanol (logKp= −3.88) &lt; 2-(2-butoxyethoxy)ethanol) (logKp= −4.45). To confirm this tendency, we have calculated permeability for two additional glycol ethers. We found that 2-(2-propoxyethoxy)ethanol (logKp pred = −4.05), which had an logKppred intermediary between 2-(2-ethoxyethoxy)ethanol and 2-(2-butoxyethoxy)ethanol, followed the trend but our predictions indicated a slight increase in permeability for 2-(2-(pentyloxy)ethoxy)ethanol (logKp pred = −3.95). Then, with further increase of the chain length, this effect reached saturation resulting in a highly similar permeability for the next three compounds: 2-(2-(hexyloxy)ethoxy)ethanol (logKp pred = −3.88), 2-(2-(heptyloxy)ethoxy)ethanol (logKp pred = −3.87), and 2-(2-(octyloxy)ethoxy)ethanol (logKp pred −3.89). Two compounds, 2-(2-(nonyloxy)ethoxy)ethanol and 2-(2-(decyloxy)ethoxy)ethanol were outside of the AD for the consensus model 5.</p><p>As a result of cluster analysis, we found three compounds that had different activity annotations from the rest of the cluster members and were therefore suspicious. These compounds included a barbiturate (amylobarbital) and two steroid derivatives of hydrocortisone (hydrocortisone methylsuccinate, and hydrocortisone succinamate). Our procedure for evaluating suspicious compounds was based on the permeability prediction for these compounds using developed models and a search for additional experimental data to verify their human skin permeability coefficients. Unfortunately, we were unable to find any confirmatory data in the literature to prove or refute the values of permeability coefficients for these substances. According to our consensus model 5, amylobarbital had a predicted logKp = −3.56 (experimental logKp= −2.64) similar to other barbitals: barbital (logKp = −3.95), phenobarbital (logKp = −3.34), and butobarbital (logKp = −3.71), which made us less confident in the accuracy of the reported permeability of this compound. Within steroids (cluster c in <ref type="figure">Figure 2</ref>), progesterone was the strongest penetrant (logKp = −1.89), whereas the addition of one hydroxyl group in position 17 of the steroid scaffold significantly decreased the permeability (hydroxyprogesterone logKp = −3.22). The hydroxyl group in position 17 appears to be bad for steroid permeability, since testosterone (logKp = −3.40) contains the hydroxyl group but lacks the ethoxy group. We removed both hydroxyl and ethoxy group from position 17, and the resulting compound, 3-oxo-delta4-steroid, had a predicted logKp pred = −2.28; adding a methyl group to the same position resulted in a logKp pred = −2.28, which was higher than the permeability of hydroxyprogesterone and testosterone, but lower than that of progesterone. The presence of other substituents and positions of double bonds seemed to be less important. The effects of the substituent in position 21 on compound permeability seem to depend on its size: it decreases when a methyl substituent (methylsuccinate; logKp = −3.68) is replaced by a larger group (succinamate substituent; logKp = −4.59) but dramatically increases as shown in the four hydrocortisone derivatives (hydrocortisone hexanoate, hydrocortisone octanoate, hydrocortisone methylpimelate, and hydrocortisone hemipimelate) that have a long chain in this position (see <ref type="table">Table S4</ref>). In the beginning of the homological series of compounds, the permeability of carboxylic acids (cluster a in <ref type="figure">Figure  2</ref>) increased proportionally to the length of the hydrocarbon chain, i.e., acetic acid (logKp = −3.21) &lt; propionic acid (logKp = −2.74) &lt; butanoic acid (logKp = −2.90) &lt; pentanoic acid (logKp = −2.70) &lt; hexanoic acid (logKp = −1.85) &lt; heptanoic acid (logKp = −1.70) &lt; octanoic acid (logKp = −1.60). Then, similarly to glycol ethers from cluster b, the effect reached saturation and predicted logKp values for five next carboxylic acids became very similar: nonanoic acid (logKp pred = −1.68), decanoic acid (logKp pred = −1.68), undecanoic acid (logKp pred = −1.71), dodecanoic acid (logKp pred = −1.82), and tridecanoic acid (logKp pred = −1.84).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>QSAR modeling of skin permeability</head><p>We have employed a dataset <ref type="bibr" target="#b8">(Chauhan and Shakya, 2010)</ref> comprising 211 compounds (dataset D). Several structural duplicates were identified during the curation process. The complete list of 17 duplicate pairs and two sets of triplicates is shown in <ref type="table">Table S3</ref>. Skin permeability values for all pairs of duplicates were the same or almost the same. This observation also means that the statistical performance of the models developed in an earlier study <ref type="bibr" target="#b8">(Chauhan and Shakya, 2010)</ref> may have been over-optimistic because, as shown previously <ref type="bibr" target="#b17">(Fourches et al., 2010)</ref>, the presence of duplicates with identical activity annotations in both training and test sets generally leads to an overestimation of the model's predictivity. Here, we built species-specific QSAR models of skin permeability using the same protocol used for the skin sensitization study <ref type="bibr" target="#b1">(Alves et al., 2014)</ref>. The results shown in <ref type="table" target="#tab_1">Table 1</ref> suggest that continuous models with high accuracy for both datasets have been generated; however, the quality and coverage of human-based models 12 and 14 were higher than the same characteristics of rodent-based model 21. The former models have been retained for in silico screening of chemical libraries.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comparison of developed QSAR models vs. DERMWIN permeability predictions</head><p>The DERMWIN module available as part of the EPI Suite software has been employed in several recent studies <ref type="bibr" target="#b15">(Fong and Tong, 2012;</ref><ref type="bibr" target="#b16">Fong et al., 2014;</ref><ref type="bibr" target="#b49">Zhang et al., 2013)</ref> for evaluating skin permeability. For this reason, we decided to compare our models with that implemented in this software. DERMWIN uses a linear equation that relates the permeability coefficient with the chemical's octanol/water partition coefficient and molecular weight. However, statistical characteristics of this model suggested that this correlation was not adequate to predict human permeability. Although our consensus model 12 had a lower coverage of chemical space than DERMWIN (77% vs. 100%), it significantly outperformed DERMWIN in predictivity (Q 2 ext = 72% vs. 43%, respectively) (see <ref type="table" target="#tab_1">Table 1</ref>). When the AD restriction was removed and the predictive accuracy of the models was evaluated using the same set of compounds (143 compounds), the comparison was in favor of our model (Q 2 ext = 71% vs. 66%, respectively) (see <ref type="table">Table 3</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Can rodent skin permeability data be used to predict human permeability?</head><p>As presented in the Results section, we found 34 compounds that had experimental permeability coefficient data for both human and rodents. Although the overall correlation between skin permeability measured in these two species was not high, we wished to determine whether the model obtained on rodent dataset E could be used to predict skin permeability in humans. Virtual screening of the human dataset D using the model developed with the rodent data resulted in a reasonably high predictivity (Q 2 ext = 0.77, RMSE = 1.27) but only for a very small fraction (19%) of compounds. Based on these results, one can assume that the rodent model could be used for predicting human skin permeability for at least some compounds within the conservative AD, but this observation should be considered with caution since it does not hold true for a larger data set. Additional experimental results for greater number of compounds are needed for more definitive conclusions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Relationships between skin sensitization potential and skin permeability based on computed data</head><p>Given the small number of compounds with known experimental values of both skin sensitization and permeability, we decided to apply our selected QSAR models to crosspredict these properties. The use of QSAR-imputed permeability and sensitization data allowed us to examine the possible relationships between the two endpoints for a much larger set of compounds. Skin sensitization model 5 (see the companion paper <ref type="bibr" target="#b1">(Alves et al., 2014)</ref>) was used for predicting skin sensitization for 186 compounds in the human skin permeability dataset (D), whereas skin permeability model 5 <ref type="table" target="#tab_1">(Table 1)</ref> was used for calculating permeability coefficients for 387 compounds in the skin sensitization dataset retrieved from ICCVAM (254 compounds from dataset A + 133 sensitizers from dataset B) (see <ref type="bibr" target="#b1">(Alves et al., 2014)</ref>). Then, we combined all predictions for compounds with unavailable experimental data (see <ref type="table">Table S5</ref>). Compounds outside of AD either for model 5 or 12 were removed from the analysis. In the end, 283 compounds that had information (experimental or predicted) for both endpoints were considered for the analysis. As one can see in <ref type="figure">Figure S1</ref>, all but one of the weakest penetrants (logKp &lt; −5) were non-sensitizers. The only exception was 1-dodecyl glycidyl ether, which could have been mispredicted by model 5. It was hypothesized recently that compound accumulation in the skin is contributing more significantly to skin sensitization than its actual permeability through the skin layer <ref type="bibr" target="#b20">(Jaworska et al., 2013)</ref>. Our results (see <ref type="figure">Figure S1)</ref> show that easily-penetrating compounds may be both sensitizers and non-sensitizers. For compounds with low permeability we made the same observation. These findings re-confirm the absence of the global correlation between skin permeability and sensitization.</p><p>Aforementioned results contradict a common view of skin permeation as the first step in the adverse outcome pathway leading to skin sensitization <ref type="bibr">(OECD, 2012)</ref>. To investigate whether the concordance between skin sensitization and permeability could be confined to certain chemical classes, we have performed a cluster analysis for the entire dataset of 283 compounds with imputed data. Careful analysis of the relationships between the two endpoints within clusters of structurally similar compounds showed that the observation linking the high permeability and skin sensitization potential could be made only for one cluster out of 34. This specific Cluster 1 is formed by 11 compounds represented by four barbitals <ref type="bibr">(barbital, amylobarbital, butobarbital, and phenobarbital)</ref> and seven other drugs <ref type="bibr">(scopolamine, ibuprofen, atropine, griseofulvin, cyclamen aldehyde, p-tert-butyl-alphaethyl-hydrocinnamal, and sodium-3,3,5-trimethyl-benzenesulfonate)</ref>. The comparison between permeability and sensitization for compounds in this cluster is shown in <ref type="figure">Figure S2</ref> and <ref type="table">Table S6</ref>. The analysis revealed that seven compounds are associated with logKp &lt; −2.5 and are non-sensitizers, whereas the four other compounds with logKp &gt; −2.5 are sensitizers.</p><p>No distinct trend could be observed for the remaining clusters. Although, as noticed above, skin permeability is widely considered to be mechanistically implicated in skin sensitization, we have found no evidence that high permeability implies high skin sensitization potency and vice versa. Some other authors reached the same conclusions. For instance, the analysis of mechanism-based QSARs demonstrates no role for skin permeability in determining potency <ref type="bibr" target="#b40">(Roberts and Aptula, 2008)</ref>. Similarly, in another recent study <ref type="bibr" target="#b20">(Jaworska et al., 2013)</ref> the authors hypothesizes that the accumulation of a chemical in the epidermis layer of the skin is much more related to the skin sensitization than the actual penetration properties. In another study <ref type="bibr" target="#b41">(Roberts and Patlewicz, 2010)</ref>, it was hypothesized that skin sensitizers reach the viable epidermis by-passing skin permeability route via shunt pathways, since bad penetrants have shown to be sensitizers when applied by intradermal injection.</p><p>Another important benefit of this cheminformatics analysis is the use of structural rules established from the interpretation of developed QSAR models, SAR and cluster analysis, in order to design new compounds with improved permeability and sensitization characteristics. We illustrated this approach using an example of putative stepwise structural optimization for permeability of pentanoic acid, considering experimental data and predictions using developed models <ref type="figure">(Figure 3</ref>). Starting from this compound with a relatively low permeability (logKp = −2.7), several transformation steps can increase its permeability more than 10-fold and convert it to n-heptanol (logKp = −1.50). n-heptanol is predicted as a sensitizer (which is confirmed by its Material Safety Data Sheet (OXEA, 2013) but it can be transformed to octanoic acid that has a similar permeability (logKp = −1.60) as n-heptanol but lacks its sensitization potential.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSIONS</head><p>We have compiled, curated, and integrated the largest publicly available datasets of skin permeability for diverse chemicals. The analysis of the experimental data for compounds containing both skin sensitization and permeability data indicated that, with a few exceptions, there is no overall concordance between these two endpoints, i.e., weak penetrants could be strong sensitizers and vice versa. Although sensitizers have to penetrate the skin layer, the permeability coefficient is not a determinant of the skin sensitization potential. Cluster analysis also helped us to highlight the high consistency of experimental Kp data reported in the literature.</p><p>We have built statistically significant and externally predictive QSAR models of skin permeability that can be used to predict the permeability of untested compounds through the skin. Comparison of the developed consensus model with DERMWIN software showed that our model significantly outperformed DERMWIN in predictivity (Q 2 ext = 72% and 43%, respectively) but at the expense of some lost in coverage (77% vs. 100%); when applied to the same set of compounds as used for DERMWIN (ignoring the AD for our models) the performance of our model is still higher (Q 2 ext = 71% vs. 66%). The compiled datasets and all the models developed in this study have been made publicly available at the Chembench Web Portal (http://chembench.mml.unc.edu).</p><p>The use of skin permeability and sensitization values imputed by our QSAR models allowed us to examine the relationships between these two endpoints utilizing a significantly expanded set consisting of 283 compounds. The results indicated that there is still no overall concordance between these endpoints. This phenomenon could be explained by attributing higher impact to compound accumulation in the skin on sensitization potential, rather than permeability through the skin layer. Further investigation into this observation would be facilitated via building predictive models of compound accumulation in the skin, and incorporating considerations of protein binding and reactivity.</p><p>In conclusion, the skin permeability models developed in this study could be useful for risk assessment purposes in addition to the assessment of skin sensitization; for instance, the knowledge how much of an applied dose will penetrate the skin may be helpful to estimate systemic exposure to topically applied chemicals. Moreover, the lack of correlation between skin permeability and skin sensitization established in this study suggests a possibility of rational design of compounds with the desired high permeability but low skin sensitization potential that may be of value to the cosmetics industry. Human vs. rodent skin permeability correlation (R 2 = 0.44, logKp Human = 0.72*logKp Rodent − 1.17). Cluster analysis of the human skin permeability dataset D: dendrogram and heat map of the distance matrix ordered based on structural similarity (blue/violet = similar; yellow/red = dissimilar). The following clusters are noted: (a) carboxylic acids, (b) glycol ethers, and (c) steroids. Example of a structural transformation of sensitizer n-octanol with low permeability to nonsensitizer octanoic acid with improved permeability. Desired change of property is highlighted by green, undesired -by red; Δ = logKp parent − logKp child . Statistical characteristics of QSAR models for skin permeability assessed by 5-fold external cross-validation. Applicability Domain was not considered in these models.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 2</head><p>Comparison of experimental data on skin sensitization and human skin permeability Chemical compound LLNA Result logKp <ref type="table">Table 3</ref> Comparison of the performance of consensus QSAR model with that of DERMWIN on the set of 143 compounds. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc>Figure 1.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc>Figure 2.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc>Figure 3.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc>1 to 7: Human-based skin permeability models. Models 8 to 13: Rodent-based skin permeability models. RSME: root mean square error; MAE: mean absolute error *</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc>Dermal Permeability Coefficient Program (DERMWIN) is a module available in the EPI Suite package developed by the EPA's Office of Pollution Prevention Toxics and Syracuse Research Corporation and available at http://www.epa.gov/oppt/ exposure/pubs/episuitedl.htm. The DERMWIN v.2.02 estimates chemicals' dermal permeability coefficient using the following equation 1 (USEPA, 2004):</figDesc><table><row><cell>(1)</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1</head><label>1</label><figDesc></figDesc><table /><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Toxicol Appl Pharmacol. Author manuscript; available in PMC 2016 April 15.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENTS</head><p>This study was supported in part by NIH (grants GM66940 and GM096967), EPA (grant RD 83499901), and FAPEG (grant 201310267001095). A.T. acknowledges partial support from Russian Scientific Foundation (project 14-43-00024). E.M. acknowledges partial support from STCU (Grant P407) E.M, V.A., and C.H.A acknowledge partial support from CNPq (PVE, Grant 400760/2014-2). V.A. thanks CNPq and Science without Borders program for the financial support of his visit to the University of North Carolina at Chapel Hill. N.K. and J.S. are supported by the NIEHS contract N01-ES 35504 and the Intramural Research Program of the NIEHS. This article may be the work product of an employee or group of employees of the NIEHS, NIH, or other organizations; however, the statements, opinions, or conclusions contained therein do not necessarily represent the statements, opinions, or conclusions of NIEHS, NIH, the United States government, or other organizations. The use of commercial product names is for comparative purposes only and does not constitute endorsement by any of the authors, organizations, or agencies.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p>Refer to Web version on PubMed Central for supplementary material.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ICCVAM</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Interagency Coordinating Committee on the Validation of Alternative Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Kp</head><p>Permeability coefficient We compiled the largest publicly-available skin permeability dataset.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>LLNA</head><p>• Predictive QSAR models were developed for skin permeability.</p><p>• No concordance between skin sensitization and skin permeability has been found.</p><p>• Structural rules for optimizing sensitization and penetration were established.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Hydrogen bonding part 46: a review of the correlation and prediction of transport properties by an lfer method: physicochemical properties, brain penetration and skin permeability</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">H</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harpreet</forename><forename type="middle">S</forename><surname>Chadha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Filomena</forename><surname>Martins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">C</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">W</forename><surname>Bradbury</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Julie</forename><forename type="middle">A</forename><surname>Gratton</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1096-9063(199901)55:1&lt;78::aid-ps853&gt;3.0.co;2-7</idno>
		<idno type="ark">ark:/67375/WNG-KKZFVFNV-B</idno>
		<idno type="istexId">D7088A4604DBB8B2A518CDA14DAEFAEF92734CEC</idno>
	</analytic>
	<monogr>
		<title level="j">Pesticide Science</title>
		<title level="j" type="abbrev">Pestic. Sci.</title>
		<idno type="ISSN">0031-613X</idno>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="78" to="88" />
			<date type="published" when="1999-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Predicting chemically-induced skin reactions. Part I: QSAR models of skin sensitization and their application to identify potentially hazardous compounds</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vinicius</forename><forename type="middle">M</forename><surname>Alves</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eugene</forename><surname>Muratov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Denis</forename><surname>Fourches</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Judy</forename><surname>Strickland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicole</forename><surname>Kleinstreuer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carolina</forename><forename type="middle">H</forename><surname>Andrade</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Tropsha</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.taap.2014.12.014</idno>
		<idno type="PMID">25560674</idno>
		<idno type="PMCID">PMC4546933</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc4546933?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Toxicology and Applied Pharmacology</title>
		<title level="j" type="abbrev">Toxicology and Applied Pharmacology</title>
		<idno type="ISSN">0041-008X</idno>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="262" to="272" />
			<date type="published" when="2015-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>Submitted</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">QSAR analysis of the toxicity of nitroaromatics inTetrahymena pyriformis: structural factors and possible modes of action</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">G</forename><surname>Artemenko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">N</forename><surname>Muratov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">E</forename><surname>Kuz’min</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">N</forename><surname>Muratov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">V</forename><surname>Varlamova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">V</forename><surname>Kuz’mina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">G</forename><surname>Gorb</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Golius</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">C</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Leszczynski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Tropsha</surname></persName>
		</author>
		<idno type="DOI">10.1080/1062936x.2011.569950</idno>
		<idno type="PMID">21714735</idno>
		<idno type="PMCID">PMC3442116</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3442116?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">SAR and QSAR in Environmental Research</title>
		<title level="j" type="abbrev">SAR and QSAR in Environmental Research</title>
		<idno type="ISSN">1062-936X</idno>
		<idno type="ISSNe">1029-046X</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5-6</biblScope>
			<biblScope unit="page" from="575" to="601" />
			<date type="published" when="2011-07" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 21714735</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Quantitative structure-activity relationships for skin permeability</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Barratt</surname></persName>
		</author>
		<idno type="DOI">10.1016/0887-2333(94)00190-6</idno>
		<idno type="PMID">20650060</idno>
		<idno type="PII">0887-2333(94)00190-6</idno>
		<idno type="ark">ark:/67375/6H6-31MC3PX6-X</idno>
		<idno type="istexId">5B290EDC7B02399E78C297A676D3A19D1722BCCC</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology in Vitro</title>
		<title level="j" type="abbrev">Toxicology in Vitro</title>
		<idno type="ISSN">0887-2333</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="27" to="37" />
			<date type="published" when="1995-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 20650060</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">A simple dermal absorption model: Derivation and application</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Berge</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.chemosphere.2009.02.043</idno>
		<idno type="PMID">19304310</idno>
	</analytic>
	<monogr>
		<title level="j">Chemosphere</title>
		<title level="j" type="abbrev">Chemosphere</title>
		<idno type="ISSN">0045-6535</idno>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1440" to="1445" />
			<date type="published" when="2009-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 19304310</note>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m" type="main">Classification And Regression Trees</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leo</forename><surname>Breiman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Olshen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Stone</surname></persName>
		</author>
		<idno type="DOI">10.1201/9781315139470</idno>
		<imprint>
			<date type="published" when="2017-10-19" />
			<publisher>Routledge</publisher>
			<pubPlace>Belmont</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Random Forests</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leo</forename><surname>Breiman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mach. Learn</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="5" to="32" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">An evaluation of the potential of linear and nonlinear skin permeation models for the prediction of experimentally measured percutaneous drug absorption</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marc</forename><forename type="middle">B</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chi-Hian</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sian</forename><forename type="middle">T</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Neail</forename><surname>Davey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gary</forename><forename type="middle">P</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seon-Hie</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christian</forename><surname>De Muynck</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.2042-7158.2011.01436.x</idno>
		<idno type="PMID">22420662</idno>
		<idno type="ark">ark:/67375/WNG-W32PHDFS-5</idno>
		<idno type="istexId">943043F251FBDB6C283DFC1666885699A97E3B31</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacy and Pharmacology</title>
		<idno type="ISSN">0022-3573</idno>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="566" to="577" />
			<date type="published" when="2012-02-07" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Role of physicochemical properties in the estimation of skin permeability:in vitrodata assessment by Partial Least-Squares Regression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Chauhan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Shakya</surname></persName>
		</author>
		<idno type="DOI">10.1080/1062936x.2010.501819</idno>
		<idno type="PMID">20818583</idno>
	</analytic>
	<monogr>
		<title level="j">SAR and QSAR in Environmental Research</title>
		<title level="j" type="abbrev">SAR and QSAR in Environmental Research</title>
		<idno type="ISSN">1062-936X</idno>
		<idno type="ISSNe">1029-046X</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5-6</biblScope>
			<biblScope unit="page" from="481" to="494" />
			<date type="published" when="2010-07" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 20818583</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Recent advances in predicting skin permeability of hydrophilic solutes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Longjian</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lujia</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guoping</forename><surname>Lian</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.addr.2012.05.001</idno>
		<idno type="PMID">22580335</idno>
	</analytic>
	<monogr>
		<title level="j">Advanced Drug Delivery Reviews</title>
		<title level="j" type="abbrev">Advanced Drug Delivery Reviews</title>
		<idno type="ISSN">0169-409X</idno>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="295" to="305" />
			<date type="published" when="2013-02" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 22580335</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Modeling transdermal permeation. Part I. Predicting skin permeability of both hydrophobic and hydrophilic solutes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Longjian</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guoping</forename><surname>Lian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lujia</forename><surname>Han</surname></persName>
		</author>
		<idno type="DOI">10.1002/aic.12048</idno>
		<idno type="ark">ark:/67375/WNG-XQQZXKC7-7</idno>
		<idno type="istexId">7B4456FF3FCA9DC3748BE64C568D4C2CACB96487</idno>
	</analytic>
	<monogr>
		<title level="j">AIChE Journal</title>
		<title level="j" type="abbrev">AIChE J.</title>
		<idno type="ISSN">0001-1541</idno>
		<idno type="ISSNe">1547-5905</idno>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="NA" to="NA" />
			<date type="published" when="2009" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Prediction of human skin permeability using artificial neural network (ANN) modeling</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Long-Jian</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guo-Ping</forename><surname>Lian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lu-Jia</forename><surname>Han</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1745-7254.2007.00528.x</idno>
		<idno type="PMID">17376301</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/aps200776.pdf" />
	</analytic>
	<monogr>
		<title level="j">Acta Pharmacologica Sinica</title>
		<title level="j" type="abbrev">Acta Pharmacologica Sinica</title>
		<idno type="ISSN">1671-4083</idno>
		<idno type="ISSNe">1745-7254</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="591" to="600" />
			<date type="published" when="2007-04" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 17376301</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Investigation of the mechanism of flux across human skin in vitro by quantitative structure–permeability relationships</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">T D</forename><surname>Cronin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Dearden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">P</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Murray-Dickson</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0928-0987(98)00041-4</idno>
		<idno type="PMID">9971916</idno>
		<idno type="PII">S0928-0987(98)00041-4</idno>
		<idno type="ark">ark:/67375/6H6-GH2SJKTZ-D</idno>
		<idno type="istexId">B0F1592DDE312604EED3657C8AC1F4FF3ED2820C</idno>
	</analytic>
	<monogr>
		<title level="j">European Journal of Pharmaceutical Sciences</title>
		<title level="j" type="abbrev">European Journal of Pharmaceutical Sciences</title>
		<idno type="ISSN">0928-0987</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="325" to="330" />
			<date type="published" when="1999-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 9971916</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Clustering Methods and Their Uses in Computational Chemistry</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Geoff</forename><forename type="middle">M</forename><surname>Downs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">M</forename><surname>Barnard</surname></persName>
		</author>
		<idno type="DOI">10.1002/0471433519.ch1</idno>
	</analytic>
	<monogr>
		<title level="m">Reviews in Computational Chemistry, Volume 18</title>
		<editor>Lipkowitz, KB.</editor>
		<editor>Boyd, DB.</editor>
		<meeting><address><addrLine>Hoboken</addrLine></address></meeting>
		<imprint>
			<publisher>John Wiley &amp; Sons, Inc.</publisher>
			<date>2003</date>
			<biblScope unit="page" from="1" to="40" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Principles of Route-to-Route Extrapolation for Risk Assessment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">L</forename><surname>Flynn</surname></persName>
		</author>
		<editor>Gerrity, TR.</editor>
		<editor>Henry, CJ.</editor>
		<imprint>
			<date type="published" when="1990" />
			<publisher>Elsevier</publisher>
			<biblScope unit="page" from="93" to="117" />
			<pubPlace>New York, NY</pubPlace>
		</imprint>
	</monogr>
	<note>Physicochemical determinants of skin absorption</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">In silico prediction of the cosmetic whitening effects of naturally occurring lead compounds</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hhy</forename><surname>Tong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Prod. Commun</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1287" to="1294" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
	<note>PubMed: 23156992</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">In silico prediction of tyrosinase and adenylyl cyclase inhibitors from natural compounds</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hhy</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Chao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Prod. Commun</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="189" to="194" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note>PubMed: 24689287</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Denis</forename><surname>Fourches</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eugene</forename><surname>Muratov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Tropsha</surname></persName>
		</author>
		<idno type="DOI">10.1021/ci100176x</idno>
		<idno type="PMID">20572635</idno>
		<idno type="PMCID">PMC2989419</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2989419?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Journal of Chemical Information and Modeling</title>
		<title level="j" type="abbrev">J. Chem. Inf. Model.</title>
		<idno type="ISSN">1549-9596</idno>
		<idno type="ISSNe">1549-960X</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1189" to="1204" />
			<date type="published" when="2010-07-26" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 20572635</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Fragrance allergens: Classification and ranking by QSAR</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Hostýnek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">S</forename><surname>Magee</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0887-2333(97)00031-3</idno>
		<idno type="PMID">20654324</idno>
		<idno type="PII">S0887-2333(97)00031-3</idno>
		<idno type="ark">ark:/67375/6H6-GSJNQ2J2-M</idno>
		<idno type="istexId">D37ECB4D68619C7CACCDAA033AAE406FAC978523</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology in Vitro</title>
		<title level="j" type="abbrev">Toxicology in Vitro</title>
		<idno type="ISSN">0887-2333</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="377" to="384" />
			<date type="published" when="1997-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 20654324</note>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title level="m" type="main">The reduced murine local lymph node assay: an alternative test method using fewer animals to assess the allergic contact dermatitis potential of chemicals and products</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Iccvam</surname></persName>
		</author>
		<ptr target="http://ntp.niehs.nih.gov/iccvam/docs/immunotox_docs/LLNA-LD/TMER.pdf" />
		<imprint>
			<date type="published" when="2009" />
		</imprint>
	</monogr>
	<note>accessed 2.20.12</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanna</forename><surname>Jaworska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuri</forename><surname>Dancik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Petra</forename><surname>Kern</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><surname>Gerberick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><surname>Natsch</surname></persName>
		</author>
		<idno type="DOI">10.1002/jat.2869</idno>
		<idno type="PMID">23670904</idno>
		<idno type="ark">ark:/67375/WNG-CT4W3992-H</idno>
		<idno type="istexId">8AB5C797EEF14A5DB3819BFB0BA40FE6FA652A6D</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Applied Toxicology</title>
		<title level="j" type="abbrev">J. Appl. Toxicol.</title>
		<idno type="ISSN">0260-437X</idno>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="n/a" to="n/a" />
			<date type="published" when="2013-05" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 23670904</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Integrating non-animal test information into an adaptive testing strategy – skin sensitization proof of concept case</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joanna</forename><surname>Jaworska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Harol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">S</forename><surname>Kern</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">F</forename><surname>Gerberick</surname></persName>
		</author>
		<idno type="DOI">10.14573/altex.2011.3.211</idno>
		<idno type="PMID">21993957</idno>
		<ptr type="open-access" target="https://www.altex.org/index.php/altex/article/download/501/512" />
	</analytic>
	<monogr>
		<title level="j">ALTEX</title>
		<title level="j" type="abbrev">ALTEX</title>
		<idno type="ISSN">1868-596X</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="211" to="225" />
			<date type="published" when="2011" />
			<publisher>ALTEX Edition</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 21993957</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Allergic Contact Dermatitis in Humans — Experimental and Quantitative Aspects</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeanne</forename><forename type="middle">Duus</forename><surname>Johansen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Frosch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Torkil</forename><surname>Menné</surname></persName>
		</author>
		<idno type="DOI">10.1007/3-540-31301-x_13</idno>
	</analytic>
	<monogr>
		<title level="m">Contact Dermatitis</title>
		<editor>Johansen, JD.</editor>
		<editor>Frosch, PJ.</editor>
		<editor>Lepoittevin, J-P.</editor>
		<meeting><address><addrLine>Berlin</addrLine></address></meeting>
		<imprint>
			<publisher>Springer-Verlag</publisher>
			<date>2011</date>
			<biblScope unit="page" from="189" to="198" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Allergic Contact Dermatitis––Formation, Structural Requirements, and Reactivity of Skin Sensitizers</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ann-Therese</forename><surname>Karlberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Moa</forename><forename type="middle">Andresen</forename><surname>Bergström</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anna</forename><surname>Börje</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kristina</forename><surname>Luthman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jlg</forename><forename type="middle">Lars G</forename><surname>Nilsson</surname></persName>
		</author>
		<idno type="DOI">10.1021/tx7002239</idno>
		<idno type="PMID">18052130</idno>
	</analytic>
	<monogr>
		<title level="j">Chemical Research in Toxicology</title>
		<title level="j" type="abbrev">Chem. Res. Toxicol.</title>
		<idno type="ISSN">0893-228X</idno>
		<idno type="ISSNe">1520-5010</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="53" to="69" />
			<date type="published" when="2008-01" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 18052130</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Hierarchical QSAR technology based on the Simplex representation of molecular structure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">E</forename><surname>Kuz’min</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">G</forename><surname>Artemenko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">N</forename><surname>Muratov</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10822-008-9179-6</idno>
		<idno type="PMID">18253701</idno>
		<idno type="ark">ark:/67375/VQC-LXN1DC8L-D</idno>
		<idno type="istexId">5F6A4632A42AB8A55260619D57E54E6D1569C560</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Computer-Aided Molecular Design</title>
		<title level="j" type="abbrev">J Comput Aided Mol Des</title>
		<idno type="ISSN">0920-654X</idno>
		<idno type="ISSNe">1573-4951</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">6-7</biblScope>
			<biblScope unit="page" from="403" to="421" />
			<date type="published" when="2008-02-06" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 18253701</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Quantitative Structure−Activity Relationship Studies of [(Biphenyloxy)propyl]isoxazole Derivatives. Inhibitors of Human Rhinovirus 2 Replication</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victor</forename><forename type="middle">E</forename><surname>Kuz'min</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anatoly</forename><forename type="middle">G</forename><surname>Artemenko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eugene</forename><forename type="middle">N</forename><surname>Muratov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ingrid</forename><forename type="middle">L</forename><surname>Volineckaya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vadim</forename><forename type="middle">A</forename><surname>Makarov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olga</forename><forename type="middle">B</forename><surname>Riabova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Wutzler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michaela</forename><surname>Schmidtke</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm0704806</idno>
		<idno type="PMID">17665898</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Medicinal Chemistry</title>
		<title level="j" type="abbrev">J. Med. Chem.</title>
		<idno type="ISSN">0022-2623</idno>
		<idno type="ISSNe">1520-4804</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="4205" to="4213" />
			<date type="published" when="2007-08" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 17665898</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">QSAR analysis of skin permeability of various drugs in man as compared to in vivo and in vitro studies in rodents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Lien</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharm. Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="583" to="587" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
	<note>PubMed: 7596996</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cameron</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Summerfield</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Maxwell</surname></persName>
		</author>
		<idno type="DOI">10.14573/altex.2013.4.473</idno>
		<idno type="PMID">24173169</idno>
	</analytic>
	<monogr>
		<title level="j">ALTEX</title>
		<title level="j" type="abbrev">ALTEX</title>
		<idno type="ISSN">1868-596X</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="473" to="486" />
			<date type="published" when="2013" />
			<publisher>ALTEX Edition</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 24173169</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Molecular Size as the Main Determinant of Solute Maximum Flux Across the Skin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Beatrice</forename><forename type="middle">M</forename><surname>Magnusson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuri</forename><forename type="middle">G</forename><surname>Anissimov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sheree</forename><forename type="middle">E</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">S</forename><surname>Roberts</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.0022-202x.2004.22413.x</idno>
		<idno type="PMID">15102090</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Investigative Dermatology</title>
		<title level="j" type="abbrev">Journal of Investigative Dermatology</title>
		<idno type="ISSN">0022-202X</idno>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="993" to="999" />
			<date type="published" when="2004-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Clustering large datasets</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Mercier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Electron. Rev. -Linacre Coll</title>
		<imprint>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Quantitative structure–permeability relationships for percutaneous absorption: re-analysis of steroid data</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gary</forename><forename type="middle">P</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">T D</forename><surname>Cronin</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0378-5173(02)00057-1</idno>
		<idno type="PMID">11996814</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Pharmaceutics</title>
		<title level="j" type="abbrev">International Journal of Pharmaceutics</title>
		<idno type="ISSN">0378-5173</idno>
		<imprint>
			<biblScope unit="volume">238</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="105" to="109" />
			<date type="published" when="2002-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 11996814</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">The application and limitations of mathematical modelling in the prediction of permeability across mammalian skin and polydimethylsiloxane membranes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gary</forename><forename type="middle">P</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Simon</forename><forename type="middle">C</forename><surname>Wilkinson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Neil</forename><surname>Davey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rod</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gary</forename><forename type="middle">P</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Prapopopolou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marc</forename><forename type="middle">B</forename><surname>Brown</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.2042-7158.2011.01345.x</idno>
		<idno type="PMID">21988422</idno>
		<idno type="ark">ark:/67375/WNG-GW5HL4MC-L</idno>
		<idno type="istexId">4D1D728A784809BFC982AB72D4C48A25D45081C5</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacy and Pharmacology</title>
		<idno type="ISSN">0022-3573</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1411" to="1427" />
			<date type="published" when="2011-08-30" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 21988422</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Per aspera ad astra: application of Simplex QSAR approach in antiviral research</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eugene</forename><forename type="middle">N</forename><surname>Muratov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anatoly</forename><forename type="middle">G</forename><surname>Artemenko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ekaterina</forename><forename type="middle">V</forename><surname>Varlamova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pavel</forename><forename type="middle">G</forename><surname>Polischuk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victor</forename><forename type="middle">P</forename><surname>Lozitsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alla</forename><forename type="middle">S</forename><surname>Fedchuk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Regina</forename><forename type="middle">L</forename><surname>Lozitska</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tat’yana</forename><forename type="middle">L</forename><surname>Gridina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ludmila</forename><forename type="middle">S</forename><surname>Koroleva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vladimir</forename><forename type="middle">N</forename><surname>Sil’nikov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angel</forename><forename type="middle">S</forename><surname>Galabov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vadim</forename><forename type="middle">A</forename><surname>Makarov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olga</forename><forename type="middle">B</forename><surname>Riabova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Wutzler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michaela</forename><surname>Schmidtke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victor</forename><forename type="middle">E</forename><surname>Kuz’min</surname></persName>
		</author>
		<idno type="DOI">10.4155/fmc.10.194</idno>
		<idno type="PMID">21426164</idno>
	</analytic>
	<monogr>
		<title level="j">Future Medicinal Chemistry</title>
		<title level="j" type="abbrev">Future Medicinal Chemistry</title>
		<idno type="ISSN">1756-8919</idno>
		<idno type="ISSNe">1756-8927</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1205" to="1226" />
			<date type="published" when="2010-07" />
			<publisher>Future Science, LTD</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 21426164</note>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title level="m" type="main">OECD principles for the validation, for regulatory purposes, of (Quantitative) Structure-Activity Relationship models</title>
		<ptr target="http://www.oecd.org/chemicalsafety/risk-assessment/37849783.pdf" />
		<imprint>
			<date type="published" when="2004" />
			<publisher>WWW Document</publisher>
		</imprint>
		<respStmt>
			<orgName>OECD</orgName>
		</respStmt>
	</monogr>
	<note>accessed 4.11.13</note>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<title level="m" type="main">The adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins part 1: scientific evidence</title>
		<ptr target="http://search.oecd.org/officialdocuments/displaydocumentpdf/?cote=env/jm/mono" />
		<imprint>
			<date type="published" when="2012" />
			<publisher>WWW Document</publisher>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">1</biblScope>
		</imprint>
		<respStmt>
			<orgName>OECD</orgName>
		</respStmt>
	</monogr>
	<note>accessed 4.11.12</note>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Oxea. N-Heptanol</surname></persName>
		</author>
		<ptr target="http://www.oxea-chemicals.com/download/wercs/MTA5MDAjZW4jcHMjYXVzIzEzNjg2MTA1NzIwMDAjb3hlYSMxI0Q=/10900-en-ps-us.pdf" />
		<imprint>
			<date type="published" when="2013" />
			<publisher>WWW Document</publisher>
		</imprint>
	</monogr>
	<note>accessed 11.18.14</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Quantitative structure–activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiren</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wil</forename><forename type="middle">Ten</forename><surname>Berge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">T D</forename><surname>Cronin</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0045-6535(02)00114-5</idno>
		<idno type="PMID">12143935</idno>
	</analytic>
	<monogr>
		<title level="j">Chemosphere</title>
		<title level="j" type="abbrev">Chemosphere</title>
		<idno type="ISSN">0045-6535</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="603" to="613" />
			<date type="published" when="2002-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 12143935</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Application of Random Forest Approach to QSAR Prediction of Aquatic Toxicity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pavel</forename><forename type="middle">G</forename><surname>Polishchuk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eugene</forename><forename type="middle">N</forename><surname>Muratov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anatoly</forename><forename type="middle">G</forename><surname>Artemenko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Oleg</forename><forename type="middle">G</forename><surname>Kolumbin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nail</forename><forename type="middle">N</forename><surname>Muratov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Victor</forename><forename type="middle">E</forename><surname>Kuz’min</surname></persName>
		</author>
		<idno type="DOI">10.1021/ci900203n</idno>
		<idno type="PMID">19860412</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Chemical Information and Modeling</title>
		<title level="j" type="abbrev">J. Chem. Inf. Model.</title>
		<idno type="ISSN">1549-9596</idno>
		<idno type="ISSNe">1549-960X</idno>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2481" to="2488" />
			<date type="published" when="2009-11-23" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 19860412</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Predicting skin permeability</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">O</forename><surname>Potts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Guy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharm. Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="663" to="669" />
			<date type="published" when="1992" />
		</imprint>
	</monogr>
	<note>PubMed: 1608900</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">O</forename><surname>Potts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Guy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharm. Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1628" to="1633" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
	<note>PubMed: 8592661</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Determinants of skin sensitisation potential</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">W</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aynur</forename><forename type="middle">O</forename><surname>Aptula</surname></persName>
		</author>
		<idno type="DOI">10.1002/jat.1289</idno>
		<idno type="PMID">17703504</idno>
		<idno type="ark">ark:/67375/WNG-PS950N59-R</idno>
		<idno type="istexId">F67B1CE9E76829C2808D4D596212DD9F7F53B901</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Applied Toxicology</title>
		<title level="j" type="abbrev">J. Appl. Toxicol.</title>
		<idno type="ISSN">0260-437X</idno>
		<idno type="ISSNe">1099-1263</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="377" to="387" />
			<date type="published" when="2008" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 17703504</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Updating the Skin Sensitizationin VitroData Assessment Paradigm in 2009 - a chemistry and QSAR perspective</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">W</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Grace</forename><forename type="middle">Y</forename><surname>Patlewicz</surname></persName>
		</author>
		<idno type="DOI">10.1002/jat.1508</idno>
		<idno type="PMID">20131408</idno>
		<idno type="ark">ark:/67375/WNG-C3D6JLWG-X</idno>
		<idno type="istexId">E9E0D71815506E4007DB9CE95349509EC44D9635</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Applied Toxicology</title>
		<title level="j" type="abbrev">J. Appl. Toxicol.</title>
		<idno type="ISSN">0260-437X</idno>
		<idno type="ISSNe">1099-1263</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="n/a" to="n/a" />
			<date type="published" when="2010" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>discussion 289. PubMed: 20131408</note>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title level="m" type="main">Handbook of Molecular Descriptors, Methods and Principles in Medicinal Chemistry</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Todeschini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Consonni</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2000" />
			<publisher>Wiley-VCH</publisher>
			<pubPlace>Weinheim, Germany</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Best Practices for QSAR Model Development, Validation, and Exploitation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Tropsha</surname></persName>
		</author>
		<idno type="DOI">10.1002/minf.201000061</idno>
		<idno type="PMID">27463326</idno>
		<idno type="ark">ark:/67375/WNG-CZV12101-9</idno>
		<idno type="istexId">BE7E9D66A7065C639D53B15D55499DC9B8E40E9F</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Informatics</title>
		<title level="j" type="abbrev">Mol. Inf.</title>
		<idno type="ISSN">1868-1743</idno>
		<idno type="ISSNe">1868-1751</idno>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">6-7</biblScope>
			<biblScope unit="page" from="476" to="488" />
			<date type="published" when="2010-07-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Predictive QSAR Modeling Workflow, Model Applicability Domains, and Virtual Screening</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Tropsha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Golbraikh</surname></persName>
		</author>
		<idno type="DOI">10.2174/138161207782794257</idno>
		<idno type="PMID">18220786</idno>
	</analytic>
	<monogr>
		<title level="j">Current Pharmaceutical Design</title>
		<title level="j" type="abbrev">CPD</title>
		<idno type="ISSN">1381-6128</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">34</biblScope>
			<biblScope unit="page" from="3494" to="3504" />
			<date type="published" when="2007-12-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 18220786</note>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">Risk Assessment Guidance for Superfund (RAGS), Volume I: Human Health Evaluation Manual (Part E Supplemental Guidance for Dermal Risk Assessment) Interim</title>
		<ptr target="http://www.epa.gov/oswer/riskassessment/ragse/index.htm" />
		<imprint>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>USEPA. WWW Document. accessed 5.13.13</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">ISIDA - Platform for Virtual Screening Based on Fragment and Pharmacophoric Descriptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexandre</forename><surname>Varnek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Denis</forename><surname>Fourches</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dragos</forename><surname>Horvath</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Olga</forename><surname>Klimchuk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cedric</forename><surname>Gaudin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philippe</forename><surname>Vayer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vitaly</forename><surname>Solov'ev</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><surname>Hoonakker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Igor</forename><surname>Tetko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gilles</forename><surname>Marcou</surname></persName>
		</author>
		<idno type="DOI">10.2174/157340908785747465</idno>
	</analytic>
	<monogr>
		<title level="j">Current Computer Aided-Drug Design</title>
		<title level="j" type="abbrev">CAD</title>
		<idno type="ISSN">1573-4099</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="191" to="198" />
			<date type="published" when="2008-09-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">QSPR Modeling of the AmIII/EuIIISeparation Factor: How Far Can we Predict ?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexandre</forename><surname>Varnek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Fourches</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Sieffert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">P</forename><surname>Solov'ev</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Lecomte</surname></persName>
		</author>
		<idno type="DOI">10.1080/07366290601067481</idno>
	</analytic>
	<monogr>
		<title level="j">Solvent Extraction and Ion Exchange</title>
		<title level="j" type="abbrev">Solvent Extraction and Ion Exchange</title>
		<idno type="ISSN">0736-6299</idno>
		<idno type="ISSNe">1532-2262</idno>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="26" />
			<date type="published" when="2007-03" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Quantitative Structure-Permeability Relationships</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xin-Rui</forename><forename type="middle">R</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.1002/9780470959916.ch3</idno>
	</analytic>
	<monogr>
		<title level="m">Comparative Pharmacokinetics</title>
		<editor>Riviere, JE.</editor>
		<imprint>
			<publisher>Wiley-Blackwell</publisher>
			<date type="published" when="2011-02-11" />
			<biblScope unit="page" from="27" to="38" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Molecular interactions of benzophenone UV filters with human serum albumin revealed by spectroscopic techniques and molecular modeling</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Feng</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jing</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Changlun</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yadong</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shulin</forename><surname>Zhuang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Weiping</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jhazmat.2013.10.024</idno>
		<idno type="PMID">24231334</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Hazardous Materials</title>
		<title level="j" type="abbrev">Journal of Hazardous Materials</title>
		<idno type="ISSN">0304-3894</idno>
		<imprint>
			<biblScope unit="volume">263</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="618" to="626" />
			<date type="published" when="2013-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 24231334</note>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">;</forename><surname>Notes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Chauhan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">;</forename><surname>Shakya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Jaworska</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010" />
		</imprint>
	</monogr>
	<note>ICCVAM, 2009); [3. Kp: permeability coefficient</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
